Cargando…
Treatment of rheumatoid arthritis-associated interstitial lung disease in a multi-center registry cohort
BACKGROUND: Rheumatoid arthritis-associated interstitial lung disease (RA-ILD) is challenging to manage, with a paucity of robust data to guide treatment. Our aim was to characterize the pharmacologic treatment of RA-ILD utilizing a retrospective design in a national multi-center prospective cohort,...
Autores principales: | Marcoux, Veronica, Lok, Stacey, Mondal, Prosanta, Assayag, Deborah, Fisher, Jolene H., Shapera, Shane, Morisset, Julie, Manganas, Hélène, Fell, Charlene D., Hambly, Nathan, Cox, P. Gerard, Kolb, Martin, Gershon, Andrea S., To, Teresa, Sadatsafavi, Mohsen, Khalil, Nasreen, Wong, Alyson W., Wilcox, Pierce G., Ryerson, Christopher J., Johannson, Kerri A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10267945/ https://www.ncbi.nlm.nih.gov/pubmed/37324076 http://dx.doi.org/10.21037/jtd-22-1820 |
Ejemplares similares
-
A cluster-based analysis evaluating the impact of comorbidities in fibrotic interstitial lung disease
por: Wong, Alyson W., et al.
Publicado: (2020) -
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis
por: Lee, Cathryn T., et al.
Publicado: (2022) -
Practical Considerations for the Diagnosis and Treatment of Fibrotic Interstitial Lung Disease During the Coronavirus Disease 2019 Pandemic
por: Wong, Alyson W., et al.
Publicado: (2020) -
Validation and minimum important difference of the UCSD Shortness of Breath Questionnaire in fibrotic interstitial lung disease
por: Chen, Tao, et al.
Publicado: (2021) -
The Canadian Registry for Pulmonary Fibrosis: Design and Rationale of a National Pulmonary Fibrosis Registry
por: Ryerson, Christopher J., et al.
Publicado: (2016)